SCHEMBL9938434

SCHEMBL9938434

NC(=O)CN1C=CCN=C1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7258828 0.65 KDM4E (0.31) KDM4E
SCHEMBL6209229 0.65
Caricotamide SCHEMBL6546956 0.63 LDHA (0.37) KDM4E
SCHEMBL28886735 0.60
SCHEMBL7962187 0.60 KDM4E (0.31) KDM4E
SCHEMBL9653242 0.58 KDM4E (0.30) KDM4E
SCHEMBL10503987 0.58
SCHEMBL480878 0.58 KDM4E (0.31) KDM4E
SCHEMBL480879 0.58 KDM4E (0.31) KDM4E
SCHEMBL9048947 0.58 KDM4E (0.31) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651403-A2 USE OF LP-PLA2 INHIBITORS IN THE TREATMENT AND PREVENTION OF EYE DISEASES Glaxo Group Limited (GB) 2013-10-23 EP claimed
WO-2012080497-A2 METHODS OF TREATMENT AND PREVENTION OF EYE DISEASES GLAXO GROUP LIMITED (GB) 2012-06-21 WO claimed